NIH has awarded a Phase II Small Business Innovation Research (SBIR) grant worth $640,000 to New England Biolabs (NEB) to support the development of new enzymes useful for epigenetic studies. The grant will allow the company to advance ...
Tags: NIH, NEB, Enzyme Research, Epigenetic Studies